LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...
Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) ...
Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.
What is the current status of cell therapies today? It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the ...
Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...
Eveo Cell Therapy Platform enables automated, multi-parallel intensified production of autologous cell therapies Compact ...
Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot ...
Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results